The expression of CTLA-4 in activated T cells and Treg cells has been reported to play a crucial role in the regulation of the therapeutic efficacy of ICIs in autoimmune diseases and cancer [41,52]. The gene discussed is CTLA4; the disease is autoimmune disease.